Market Overview The global hemophagocytic lymphohistiocytosis (HLH) treatment market is experiencing growth driven by disease recognition, treatment pipeline expansion, and severe case management focus. The HLH treatment market is projected to exceed USD 2.4 billion through 2030, fueled by HLH cases exceeding 50,000 annually globally, disease severity, and treatment options. HLH therapy...